for Apr 26, 2023 through May 02, 2023
Study of Novavax #COVID19 vaccine estimates 100% efficacy against hospitalizations
— CIDRAP (@CIDRAP) May 1, 2023
A post hoc analysis of a randomized, controlled trial estimates that 2 doses are 100% effective against hospitalization by 95 dayshttps://t.co/YoJ7cjGJNg pic.twitter.com/cE0LDBUU5E
Zinc is an essential mineral. Its long been known for its beneficial effects on immune health. On top of regulating immune function, zinc also aids in fighting infectious diseases like the flu and pneumonia. This is my favorite liquid zinc supplement: https://t.co/rC4MWMEOQo #ad pic.twitter.com/jn1WuWywM4
— illuminatibot (@iluminatibot) May 2, 2023
The results of this study are frankly amazing https://t.co/W1IYXwmggB pic.twitter.com/dvPxjiGwXm
— Paul Sax (@PaulSaxMD) April 28, 2023
Doxycycline for S. maltophilia pneumonia? Thoughts
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 26, 2023
🆕️⚡️🔴Small retrospective cohort study at the annals of pharmacotherapy
Comparison of Doxycycline or Minocycline to TMP-SMX for Treatment of Stenotrophomonas maltophilia Pneumonia #IDTwitter https://t.co/fefOjY3sVr
Whether it's Covid, or other dangerous infectious diseases, #vaccination remains one of the most effective ways of avoiding serious illness. In many cases (eg measles, polio) it means avoiding illness altogether.
— Stephen Parnis (@SParnis) April 26, 2023
Expertise & evidence beats ignorance. https://t.co/SPNmdV33FP
Wish us luck in the Antibiotic Guardian Shared Learning Awards this evening for our work engaging the global dental profession in antimicrobial stewardship. #DentalAntibiotics #AMR #AMS @fdiworlddental @Susie_Sanderson @Leanne_Teoh @anabalonpau @VCggsipu https://t.co/EpiZ9CjXKv
— Wendy Thompson (@wendythedentist) May 2, 2023
Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement
— Critical Care Reviews (@CritCareReviews) May 2, 2023
CCR Journal Watchhttps://t.co/Sp06oA6IDG pic.twitter.com/pxWqTyRKPI
Infectious diseases is the only specialty of medicine where things routinely get worse - drugs that used to work lose efficacy (resistance) and new diseases emerge regularly.https://t.co/fGePQqETxD
— Arturo Casadevall (@ACasadevall1) April 30, 2023
DISSOLVING 💉 ILLUSIONS
— Robin Monotti (@robinmonotti) May 2, 2023
Everything you have been told about vaccines & infectious diseases is a rewriting of history. The real credit for the eradication of disease should go to water & sewage purification engineers & housing architects. Start here:https://t.co/m2hkD943h6
CHILDREN: "Next ‘pandemic playbook’ needs to prioritize needs of children & a clear roadmap for opening schools"- a group of infectious diseases physicians in US (lots in UK) fought hard for children during pandemic including@wbranchelliman/@ShiraDoronMDhttps://t.co/i3UDZ0rkHd
— Monica Gandhi MD, MPH (@MonicaGandhi9) April 26, 2023
Vaccines are one of the most impactful scientific innovations of all time.
— World Health Organization (WHO) (@WHO) April 30, 2023
Why?
Because they help to protect generations of people against infectious diseases throughout the course of their lives.#VaccinesWork for all!https://t.co/ptPVpvcKg1 pic.twitter.com/uzzMTXQPRi
We're hiring another Antimicrobial Stewardship/ID Pharmacist at ECU Health Medical Center! Join my rapidly growing team.🧫💊Click the link for more info: https://t.co/AZYIj0LVBF
— Emily Perez (@emilyp_pharmD) May 2, 2023
FDA approved SER-109 (Vowst) as an oral fecal microbiota product to prevent CDI recurrence.
— Julie Ann Justo (@julie_justo) April 27, 2023
💊Dosing: 4 capsules PO daily x3d
Data mostly from ECOSPOR-III & ECOSPOR-IV (no FDA Ad board mtg to scour 😔).
Fingers crossed pricing is within reach…🤞🏻https://t.co/WIaCaK6HA2 pic.twitter.com/X54C6FJClW
I think people who have been infected multiple times are in for a harsh dose of reality, not just from increased chronic diseases and infectious diseases, but also from shortened lifespan from telomere damage.https://t.co/ydvRsEPH5x
— Michael Olesen 💉😷🇺🇸🇺🇦 (@maolesen) April 29, 2023
Ridinilazole, a precision antibiotic being developed to treat C. difficile infection, has a primary DNA binding mechanism. The drug could become the 1st antibiotic approved with a DNA minor groove binding mechanism of action. Learn more in #AACJournal: https://t.co/nUZHQ85kEK pic.twitter.com/3cS9BLSyos
— ASM (@ASMicrobiology) May 1, 2023
🆕️⚡️⚡️🟢Narrative review @CMIJournal Dr.Jacob Bodilsen
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 27, 2023
The author of the upcoming @ESCMID Brain abscess guidelines
The primary investigator of ORAL (brain abscess POET like )
Early switch to oral antimicrobials in brain abscess
H/t @TakaMatsuo_ID @Inox94https://t.co/5soNys5iJM pic.twitter.com/DhxhMvl5A2
Data show Omicron common cause of #COVID19 reinfections
— CIDRAP (@CIDRAP) May 1, 2023
Study shows that that the median interval between two infections was 229 days, and reinfection counts were higher during the #Omicron erahttps://t.co/YSujn2SKNX pic.twitter.com/AqfiHAIe0D
What's the matter with MICs? This @JournalSpectrum study shows MICs are an incomplete measure of how an infection will interact with an antibiotic. Understanding the critiques of MIC is one of many steps needed to improve infectious disease treatment. https://t.co/MNP7h3To3f pic.twitter.com/02zxIH1z1c
— ASM (@ASMicrobiology) April 28, 2023
Although initially considered fully susceptible to fluconazole, the emergence of fluc-resistant C parapsilosis is concerning
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 27, 2023
🌟 New review🌟 @LancetMicrobe
Worldwide emergence of fluconazole-resistant
C.parapsilosis: current framework & future researchhttps://t.co/zjDvcqNm1I pic.twitter.com/aFAhxcJcUP
Staphylococcus aureus#Antibiotic spectrum#IDtwitter
— Akshatha R, MD,DNB,MNAMS,(DM ID) (@LearnwithDrAksh) May 1, 2023
From the chapter I authored in the "Essentials of Antimicrobial stewardship"
Online version is not available
You can buy it on Amazon pic.twitter.com/lAPrHmRt3Z
Biofilm-forming microorganisms causing hospital-acquired infections from intravenous catheter: A systematic reviewhttps://t.co/IVugFDV0CB #OpenAccess pic.twitter.com/XLYaciSUIa
— MicrobesInfect (@MicrobesInfect) April 30, 2023
Back in March 2020 I thought closing schools would likely cause more harm than good. I still hold that view especially the harms from prolonged school closures.
— Peter Collignon (@CollignonPeter) April 28, 2023
More harm than good; the case for and against closing schools during the coronavirus pandemic https://t.co/u584whu9ps
How Infectious Disease Experts Impacted the Coronavirus Disease 2019 Response: Lessons From the Front Lines https://t.co/y6akS2kW3p Investigators from @JHSPH_CHS & @IDSAInfo describe the ID workforce contributions to the COVID-19) response and their impacts.
— Carlos del Rio (@CarlosdelRio7) April 29, 2023
🆕️⚡️⚡️🔴Systematic review and meta-analysis @CMIJournal@TxID_Edu
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 26, 2023
1 RCT and 14 obs studies
Ribavirin treatment for RSV infection in pts with hematologic malignancy & HSCT recipients
Ribavirin ⬇️mortality among HM/HSCT pts with LRTI
Aerosolized Vs oral🔥https://t.co/c6rU2FyAFs
🆕️⚡️⚡️@jac_amr@SadiaSarzynski
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 28, 2023
The largest study to date analysed the relationship between MIC & clinical outcomes for S.maltophilia infections
MICs w/in CLSI-suggested S range for levo did not appear to discriminate patients by risk-adjusted mortality https://t.co/FHMdSrkRto pic.twitter.com/CqRAdv86iN
Scientists identify antivirals capable of combating emerging infectious diseases. The UCLA team has pinpointed potential broad-spectrum agents that target multiple families of RNA viruses that continue to pose a significant threat for future pandemics https://t.co/dF05OP98Os
— delthia ricks 🔬 (@DelthiaRicks) April 29, 2023
Even after your primary series vaccine, boosters can help protect you and your loved ones from dangerous infectious diseases. This #WorldImmunizationWeek, take some time to learn more about the importance and purpose of boosters: https://t.co/OI5UleJts1 pic.twitter.com/XUwfvKhYtB
— Novavax (@Novavax) April 26, 2023
In @ASHE_Journal with @wbranchelliman and L Fisher.
— Shira Doron MD (@ShiraDoronMD) April 26, 2023
Schools were closed (for too long) under the assumption that they would be drivers of community COVID transmission.
That assumption was based on transmission dynamics of endemic, not novel, viruses.https://t.co/dmoOFKRZrC
At least four patients in a Seattle hospital have died in connection to an outbreak of #antibiotic-resistant Klebsiella, a bacteria often found in health care settings. https://t.co/tPah7NVhBe
— Save Antibiotics (@saveantibiotics) May 1, 2023
This systematic review and meta-analysis, including over 40 000 children and adolescents across 12 countries found an increase in depression symptoms during the pandemic, particularly among females and those from relatively higher-income backgrounds. https://t.co/rtPaHnPNds
— Peter Collignon (@CollignonPeter) May 1, 2023
📢Coming up this week!
— CIDRAP-ASP (@CIDRAP_ASP) May 1, 2023
On May 4 at 3pm GMT (10am CDT), please join @theAMRnarrative, @CIDRAP_ASP, and our moderators @_FaceSA and @FrancyChiara_ for a Twitter chat on AMR and hand hygiene#theAMRnarrative #HandHygiene #CleanHands #InfectionPreventionhttps://t.co/eGBpckftL5 pic.twitter.com/BUApPM4nvg
Super interesting ⚡️ ⚡️
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 27, 2023
Cefiderocol Resistance in Klebsiella pneumoniae "AR 0047" Is Linked to SHV ESBL Activities & Functional Loss of the Outer Membrane Porin OmpK35
Avibactam restored the activity of cefiderocol against cefiderocol-resistant KP https://t.co/N1YwZyJAKg
✅Rationale and #clinical application of #antimicrobial #stewardship principles in the #ICU
— Journal of Anesthesia, Analgesia and Critical Care (@jaacc_online) May 2, 2023
👉 https://t.co/JDdMRJI9mD@AndCorteg @PierluigiViale @AGSIAARTI2022 @maxdulac @MarcLeone8 #antimicrobialresistance #FOAMed #FOAMcc @jaacc_online @Siaarti_online pic.twitter.com/E4hi3Oueuy
By the end of 2022, an estimated 99% of the US population had some form of immunologic exposure to SARS-CoV-2 (infection or vaccination or both). https://t.co/7iioxJUG8h
— Paul Sax (@PaulSaxMD) May 2, 2023
Staphylococcus aureus UTI or something more? Check out this week's KASIC pearl and learn what to do when you see S. aureus in a urine culture! https://t.co/ENh8ElKBGr #AntimicrobialResistance #antimicrobialstewardship #IDTwitter
— KASIC.MDRO (@KASIC_MDRO) April 27, 2023
Seattle hospital says #Klebsiella outbreak has infected 31 patients
— CIDRAP (@CIDRAP) May 1, 2023
The hospital says it's unclear whether the K pneumoniae infections caused or contributed to 7 patient deathshttps://t.co/X0SjROO6DK#AMR pic.twitter.com/aXlwVRyOtJ
“Prof Peter Collignon, an expert in infectious diseases at ANU, said Arcturus may be more transmissible, but people should not panic as there is no evidence to suggest it is more severe than other Omicron subvariants.”
— 💧Sociable Socialist aka Stephen ✊🏿😷💉💉💉💉💉 (@Neopseudo) April 27, 2023
I’m no maths expert but….😳 https://t.co/WW8u5hcFsG
🚨New FDA approved C diff product!!!
— Bug Pharmacist 💊🧫 Tim Gauthier (@IDstewardship) April 27, 2023
📝 Here are my cliff notes: https://t.co/OEERLCTdIZ
🌟 It’s the first oral preventative option to hit the market 🙌
…but how much will it cost? 🤔 #Cdiff #IDtwitter #TwitteRx #Vowst pic.twitter.com/LY9f592JJ0
Fantastic review in Clinical Microbiology Reviews .@ASMicrobiology on the infectious complications from small molecule targeted therapy - major advancement in #CancerResearch still requries support from effective #antibiotics.
— ASP_MirandaS PharmD MPH (@ASP_MirandaS) May 1, 2023
.@Josh_S_Davis & colleagueshttps://t.co/tHb00QOsnI
“Bacterial infections have become more difficult, and sometimes impossible, to treat, as some have become resistant to #antibiotics,” @USGAO writes, noting progress and additional work needed by federal agencies in the fight against #superbugs. https://t.co/CZuMg1pB92
— Save Antibiotics (@saveantibiotics) May 2, 2023
Information delivered in real time has prognostic relevance
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 26, 2023
Does it affect survival?
🆕️⚡️Retrospective analysis of 6,225 adult pts with BSI@CIDJournal@ccpox @SCMIMC1
Information delay of significant bloodstream isolates & patient mortality #IDTwitter https://t.co/MQEEr6X1QB
For anyone (like me) who missed this in March or anyone who doesn't think #EnvironmentalHealth #AntimicrobialResistance #AMR is important, this is a MUST read. https://t.co/FWbBoy7DcP
— Marc Mendelson (@SouthAfricanASP) May 2, 2023
Great study! @ProMED_mail @ISID_org @OneHealthTrust @Wellcome_AMR @reactgroup @ESGAP_ABS
Great to see new Long-term Care standards including #AntimicrobialStewardship! 💊 🛡️ 🦠
— Brad Langford (@BRxAD) April 28, 2023
Now how can we best support homes to meet these important standards to keep antibiotics working?@StandardsCanada https://t.co/U7AT9Gia6O pic.twitter.com/07a4CZu3sb
Despite being the leading source of bacterial bloodstream infections, UTIs remain a chronically neglected area of infectious diseases. To look at this issue, BSAC’s are holding The Challenge of Urinary Tract Infections Conference,
— TheUrologyFoundation (@TUF_tweets) April 28, 2023
For full details - https://t.co/CtDX5Vb0c2 pic.twitter.com/cxGdo6AA6l
US lawmakers hold hearing on antimicrobial resistance
— CIDRAP (@CIDRAP) April 28, 2023
Experts in antimicrobial resistance testified on the need for better surveillance data, new antibiotics and diagnostics, and more infectious disease professionals. #AMRhttps://t.co/cwWaVKWzmH pic.twitter.com/P8TuBkIf97
“The longer bacteria remain tolerant [to #antibiotics], the more likely they are to develop mutations leading to resistance,” @Cornell’s @MRKmicrobes writes. https://t.co/KZC7q8cKAP
— Save Antibiotics (@saveantibiotics) May 2, 2023
“Tolerance allows bacteria to develop a resistance mutation that reduces their chances of being killed during #antibiotic treatment,” @Cornell’s @MRKmicrobes writes of the connection between #antibiotic tolerance and resistance. https://t.co/KZC7q8cKAP
— Save Antibiotics (@saveantibiotics) April 30, 2023
PSK in partnership with @ThisIsReckitt invites you to a webinar on:
— Pharmaceutical Society of Kenya (PSK) (@PSofKenya) April 26, 2023
📢 Antimicrobial Stewardship in Managing Upper Respiratory Tract Infections.
🗓️ 27th April 2023
⏰ 1.00 pm EAT
Register here in advance ; 🔗⤵️⤵️https://t.co/cVW3jngBip pic.twitter.com/YT8H5psKPM
Vaccination is an important step in protecting yourself from infectious diseases such as Hepatitis B and HPV. #MyDoctor | Call: +256762318431 or +256707448988 | https://t.co/EbMKY6E34S pic.twitter.com/yLxOpDgltX
— My Doctor (@MyDoctorNow) May 1, 2023
Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections in 4 U.S. Emerging Infections Program Sites:A 6-Month Pilot
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) April 27, 2023
Mycobacterium avium complex was the most common species group
Annualized prevalence was 7.5/100,000 population https://t.co/B1t2BJ2T9D
In #MMBR, researchers review and discuss in vivo infection defects of RNA and DNA viruses resulting from host antiviral RNA interference in model systems. https://t.co/hIbBjHt2t9 pic.twitter.com/Z6480wQgUI
— ASM (@ASMicrobiology) April 26, 2023
Created by Cameron Forbes. Last updated May 24, 2023 at 05:16 EST.